Difficulty: Medium
Average Score: 89%
Practice
A 45-year-old man is in the operating room under anesthesia when he develops a high fever of 104°F, a heart rate of 126 beats/minute, and a blood pressure of 178/94 mm Hg. Muscle rigidity begins to develop as well. The anesthesiologist suspects malignant hyperthermia and quickly administers a medication. The patient's vital signs and rigidity begin to improve. What is the most likely medication administered?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Dantrolene. Malignant hyperthermia is a potentially fatal condition triggered by certain anesthetics that causes uncontrolled muscle contractions, high fever, tachycardia, and elevated blood pressure. Dantrolene is the specific antidote used to treat malignant hyperthermia as it works by inhibiting calcium release from the sarcoplasmic reticulum in muscle cells, thus preventing the sustained muscle contractions and hypermetabolism associated with the condition.
Option A) Bromocriptine is a dopamine agonist used to treat conditions like Parkinson's disease and hyperprolactinemia, not malignant hyperthermia.
Option C) Diphenhydramine is an antihistamine primarily used for allergies and sleep aid, not for treating malignant hyperthermia.
Option D) Nitric oxide is a vasodilator gas used in conditions like pulmonary hypertension and neonatal respiratory distress syndrome, but it is not indicated for malignant hyperthermia.
Educationally, this question highlights the importance of recognizing and promptly treating malignant hyperthermia in the perioperative setting. Understanding the specific pharmacological interventions for this life-threatening condition is crucial for healthcare providers involved in anesthesia and perioperative care to ensure patient safety and optimal outcomes.
Option A) Bromocriptine is a dopamine agonist used to treat conditions like Parkinson's disease and hyperprolactinemia, not malignant hyperthermia.
Option C) Diphenhydramine is an antihistamine primarily used for allergies and sleep aid, not for treating malignant hyperthermia.
Option D) Nitric oxide is a vasodilator gas used in conditions like pulmonary hypertension and neonatal respiratory distress syndrome, but it is not indicated for malignant hyperthermia.
Educationally, this question highlights the importance of recognizing and promptly treating malignant hyperthermia in the perioperative setting. Understanding the specific pharmacological interventions for this life-threatening condition is crucial for healthcare providers involved in anesthesia and perioperative care to ensure patient safety and optimal outcomes.